Using symptom severity ratings of extrapyramidal side effe cts (EPS) during a 4-week antipsychotic washout period, we illustrate particular problems associated with repeated measures of symptom severity and demonstrate four analysis methods. The often suggested analysis of Vtlriance and multivariate analysis of variance found no mean change in weekly Simpson Angus scores over the 4-week washout despite the fact that 43% had clinically significant EPS prior to drug discontinuation. On the other hand, the Friedman Analysis of Ranks and KEY WORDS: Antipsychotic withdrawal; Extrapyramidal symptoms; Statistical methods; Repeated measures Researchers in psychiatry often study the processes in volved with changes in clinical status. Since the most natural means of studying changes in symptom status or other states (e.g., blood levels) is to follow subjects overtime, repeated-measures studies are widely used.
Cochran-Mantel-Haenszel (CMH) statistics found significant change over the washout period. These two less well-known techniques place fewer restrictions on the data, can be more sensitive to patterns of change, and may be more appropriate for psychiatric data. The CMH method is particularly attractive since it does not require complete data on all subjects as do many other techniques. This minimizes the number of cases lost to missing data and increases the generality of the results. [Neuropsychopharmacology 8:67-75, 1993J several advantages over other methods (Baltes and Nes selroade 1979) . In spite of these advantages, repeated measures studies frequently encounter particular prob lems (Magnusson and Bergman 1990) . For instance, the dependence among successive observations made on the same subject complicates the data analysis. Ekstrom et al. (1990) recently expressed concern over the rela tive appropriateness of two statistical techniques fre quently used for psychiatric repeated-measures data:
the repeated-measures analysis of variance (ANOV A) and the multivariate analogue (MANOVA). Among those articles that provided sufficient description to ascertain the method used (n = 41), Ekstrom et al. (1990) found that about one-half (21) of the analyses of repeated-measures data were done with either ANOV A or MANO" A.. Both the MANOV A and ANOV A share a variety of wide-reaching and restrictive assumptions.
Although we will discuss several assumptions in the context of symptom severity ratings, many of the prob lems and all of the alternatives we present apply to a 0893-133X/93/$5.00 wide range of data. Many of these assumptions are of ten inappropriate for the data of interest to psychiatric researchers.
Symptom severity measures illustrate a common problem, that response variables often are not normally distributed, nor would we expect them to be, based on the nature of symptom severity or the population of interest. However, normality is a requirement of most parametric statistical techniques including ANOV A and MANOV A. Many people may be asymptomatic or very nearly so, either because the disease process is not pres ent, has not involved the relevant system, or is in remis sion. The measurement instrument or rating scale of severity should aptly mark these individuals as such, by assigning them a zero value. On the other hand, sub jects affected with symptoms may exhibit a wide vari ety of symptom severity scores, ranging to the scale's limit. Thus, we may not even anticipate that these data are normally or even symmetrically (i.e., balanced around a center point) distributed.
A good example of the aforementioned is ratings of drug-induced parkinsonism (DIP) which is mani fested as tremor, rigidity, and akinesia individually or in combination; drooling, festinating gait, oily skin, dysarthria, and dysphagia may accompany the symp toms. Incidence estimates of DIP vary widely, ranging from 2.2% to 56% of persons receiving antipsychotic drugs (Ayd 1961; Korczyn and Goldberg 1976; Shep pard and Merlis 1967; Tarsy 1983) . Much of the varia tion in the reported percentages may be explained by differences in the antipsychotic medication prescribed, length of treatment, dose of antipsychotic, individual characteristics such a sex and age, and defInitions of extrapyramidal side effects (EPS). Generally, these reac tions are more common with high-potency than low potency antipsychotics and tend to occur most often in the elderly, with females being twice as likely to de velop them (Korczyn and Goldberg 1976; Sheppard and Merlis 1967; Man 1973) . Obviously, in any group of pa tients treated with antipsychotic drugs, there will be patients with few or no symptoms of DIP; when a rat ing scale such as the Simpson Angus (SA) scale (Simp son and Angus 1970) for EPS is used, they will have a score of less than 3. Those patients who develop DIP will have a wide range of severity with SA scores rang ing from 3 to 40. A change in antipsychotic drug dose may be associated with a change in symptom severity, but there is a large amount of variability in the amount of change. Upon discontinuation of the antipsychotic medication, DIP symptoms generally decline and of ten resolve in 7 to 10 days. However, it may take sev eral weeks to months for complete resolution, depend ing upon the drug, the dose, and the patient. During this time there can be large fluctuations in symptom severity.
There is a belief and some evidence that ANOV A and other parametric techniques are robust to violations of the normal distribution assumption. One might take this to imply that violations of the assumptions are of little concern. However, there is scant empirical evi dence that this capacity to withstand incorrect assump tions extends to the case of repeated measurements. Furthermore, Micceri (1989) recently questioned the va lidity of the studies supporting the notion that para metric analyses are robust. Most of these studies used computer simulations based on specifIc nonnormal dis tributions; however, the nonnormal distributions cho sen in the computer simulation studies do not neces sarily characterize the kinds of data seen in psychiatric and behavioral research. Although the effects of violat ing the normality assumption for repeated-measures data are largely unknown, the consequences of depar tures from the covariance assumptions of repeated measures ANOV A have been studied extensively. When the covariance assumptions are violated, the ANOV A F test of the repeated-measures factor will tend to be too liberal, producing signifIcant results too often (Box 1954a; Hearne et al. 1983 ). Tests of specifIc con trasts using general error terms are even more unsta ble (Boik 1981) and can be either positively or negatively biased.
Measures of symptom severity may violate another psychometric assumption of the commonly used para metric techniques: that the errors of measurement are independent and uncorrelated with the true status of the subject. For instance, there may be a high degree of interrater agreement on subjects who do not have symptoms of DIP but less agreement may exist for cases with moderate or high SA ratings. If the errors of mea surement are not constant across the scale, the error is "dependent on the scale." This violates a basic as sumption of many parametric statistical techniques in cluding ANOV A and MANOV A that the errors are in dependently and identically distributed.
Severity of symptoms may pose further problems for the analysis of repeated measures. The stability of a symptom's severity over time may relate to the level of symptom severity. Measurement issues aside, a sub ject without symptoms of DIP during antipsychotic treatment has a high probability of being asymptom atic during a drug washout, relative to the likelihood of a person with symptoms of DIP maintaining that same level of severity throughout the drug-free period. Subjects with less severe symptoms would show more symptom stability than people with severe symptoms. Higher variability between Time 1 and Time 2 for sub jects with more severe symptoms produces the "fan tailed" type of relationship shown in Figure 1 . This type of relationship, another example of variance dependent on the scale, also violates the assumption of homo geneity of variance found in many parametric tech niques, including both ANOV A and MANOV A. AI- though this may be seen as a problem in the scale, it most probably reflects, in large part, true manifestations and variability of the symptoms. When the usual as sumptions of parametric techniques are not compati ble with the reality of symptom severity data, alterna tives to both ANOV A and MANOV A become more attractive. Techniqu es with less restrictive assumptions about the symptom severity measurements may be more appropriate than the common parametric meth ods. We will discuss two such methods which require only that the measurement or rating scale can order peo ple or times from the least to the worst symptom severity.
In this paper, we demonstrate and discuss four meth ods of analyzing repeated measures from a single sample. Table 1 depicts the general layout of this design. Two of the analysis approaches (ANOV A, MANOVA) are the most commonly used in psychiatric research (Ek strom et al. 1990 ). Another method (the Friedman Anal ysis of Ranks) requires fewer assumptions. We also show a general methodology based on Cochran-Mantel Haenszel statistics (CMH) applicable to longitudinal data (Agresti 1990; Mantel and Haenszel 1963; Mantel 1963) . The CMH approach is particularly attractive since 
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it does not require complete data on all subjects as do the three other techniques. The data we analyze are fairly typical of repeated measures designs in psychiatric research. Ratings of the SA scale (Simpson and Angus 1970) of DIP severity were measured weekly over a 4-week antipsychotic medication washout period during which change in symptom severity was expected. Missing data is pres ent in 21 % of the subjects followed over a 5-week period (T = 5). The general null hypothesis is that the distri bution of the ratings is the same at each of the 5 weeks.
SUBJECTS AND METHODS
Subjects. Forty-three patients who underwent a 4-week antipsychotic medication washout as part of a protocol for the University of Iowa Mental Health Clinical Re search Center participated in this study. All patients met DSM III-R criteria for schizophrenia and had re ceived treatment with antipsychotic drug prior to the study. Individuals who had received depot antipsy chotics within the previous 6 months or had coexisting medical problems were excluded.
Procedures. After an initial observation of 2 to 3 days, antipsychotic medications were tapered and discon tinued over a 2-to 4-day period (mean 3.2 days) de pending on the dose of antipsychotic on which the pa tient was originally maintained (i.e., patients on higher doses underwent a longer tapering period).
Clinical Assessments. Trained research nurses made fIve weekly assessments on the SA scale for EPS. This scale rates 10 aspects (e. g. , elbow rigidity, arm drop ping) from 0 to 4 (normal to extremely symptomatic) and yields a score ranging from 0 to 40. Based on the work by Simpson and Angus (1970) , a rating of 3 or greater was defIned as clinically signifIcant EPS. The frrst observation was a baseline rating, prior to discon tinuation of antipsychotic medication, with three sub sequent measures taken during the washout period. Missing data were present in nine patients due to a va riety of reasons. For instance, one patient contracted chicken pox and returned home for 1 week.
RESULTS
Of the 43 participants, 30 were males and 13 were females with a mean age of 32.7 ± 9. 7 years (range 22 to 56 years). Sixteen patients had been taking haloperidol (mean dose 29.6 mgt day, range 5 to 85 mgt day), eleven had been taking thiothixene (mean dose 33.6 mg/day, range 5 to 80 mg/day), fIve had been taking fluphenazine (mean dose 24.4 mg/day, range 2 to 60 mg/day), three had been taking trifluoperazine (mean dose 23.0 mg/day, range 4 to 50 mg/day), two had been taking chlorpromazine (mean dose 200 mg/day), two received molidone (mean dose 50.0 mg/day, range 25 to 75 mg/day), one had been taking lozapine (dose 100 mg/day), and three patients were taking combinations of two different antipsychotics (i.e., one thioridazine and fluphenazine, one thioridazine and trifluoperazine, and one chlorpromazine and trifluoperazine).
Weekly means, medians, 75th percentiles, standard deviations, the mean diff erence, and paired t-tests com paring each week with the previous week are given in Table 2 . The medians, 75th percentiles, and means in dicate a general trend toward lower ratings in the fol lowing weeks. As might be expected, these data are not normally distributed. Since most patients do not exhibit DIP symptoms and some do, most ratings are very low, between 0 and 2. The distribution tapers off quickly but has a long tail. The relatively large standard deviations are produced by the skew in the data, occasional SA ratings between 10 and 24; thus, the data do not ap proximate a normal distribution and, in fact, have the expected shape as described in the introduction of this paper.
The pattern of the stability of scores was also of in terest. We suggested that subjects with the lowest lev els of symptom severity could be more stable from one measurement time to another compared to subjects dis playing moderate or higher levels. Indeed, 12 of the 13 people (92.3%) rated as having no symptoms at Week 1 were so rated again at Week 2. People with initial rat ings larger than zero seldom had the same rating at Week 2; only 6 of 29 people (21%) received the same score. We took the intrasubject standard deviation over time as an index of a subject's symptom stability, large numbers reflecting more week-to-week variation. That NEUROPSYCHOPHARMACOLOGY 1993 -vOL. 8, NO. 1 index correlated with the mean severity (Spearman r = 0.91, P < 0.0001) showing a dependence between stability and level of severity. Subjects' range of scores correlated similarly. Figure 2 shows the variability as each person's range of ratings ordered by their overall mean severity for the period. Higher symptom severity predicted greater variability over the period.
The Parametric Techniques: ANDV A and MANDV A We will ignore the nonnormality and other violations of assumptions for the moment and proceed with the most often used tests for time-related differences, a repeated-measures ANOV A and MANOVA. Both anal yses require complete data for all subjects and so use data for only 34 of our 43 patients.
The null hypothesis for the ANOVA is that the means at each measurement period are the same, that is, Ho: J.ll = J.l2 •.. = J.lT. In addition to assuming that the data are normally distributed, repeated-measures ANOV A requires assumptions concerning the correla tion structure of the repeated measures (Huynh and Feldt 1970) . These assumptions are not likely to be sat isned when the measures are taken over time. A sufficient but not necessary condition to ful6.l1 this as sumption requires equal variances and covariances across the time periods. As a result of the equal variance covariance condition, the correlations of the SA ratings between any two time periods should be the same. For instance, Week 1 SA ratings should correlate with Week 2 ratings about as much as Week 1 with Weeks 4 or 5. This is called the compound-symmetry, sphericity, or homogeneity of variance-covariance assumption and is frequently incorrect for longitudinal data (Ekstrom et al. 1990; Poor 1973; McCall and Appelbaum 1973) . 
Simpson Angus (SA) Ralin g Violations of this assumption do affect the signifIcance levels of the F statistics (Box 1954a; 1954b) . Although there are procedures for correcting the ANOV A re sults, they usually result in an overly conservative test (Huynh and Feldt 1976; Geisser and Greenhouse 1985; Wallenstein and Fleiss 1981) . The parametric alternative, the MANOV A ana logue of ANOVA (or the special case of Hotelling's T2) treats the data only slightly diff erently (Finn 1974; Bock 1975; Millik en and Johnson 1984) . Essentially, ANOVA questions whether the means at each time are different from one another. The MANOVA questions if any mean difference between repeated-measurement per iods is zero. Diff erences between times are constructed and considered as the variates of interest. The test for a time effect is whether the multivariates have a mean zero (Ho; 11 = 0).
Because of the multivariate nature, no assumptions are made about equal covariances or correlations among the variates. This has led some authors to recommend MANOV A over ANOV A. However, the relaxation of the equal variance-covariance assumption has costs (Bock 1975; Milliken and Johnson 1984; Lavori 1990 ). The MANOVA assumes that the data come from a mul tinormal distribution and is frequently restricted by re quiring more subjects than time points. The MANOV A also has less power than ANOV A when the ANOV A assumptions are correct.
For this sample, the F test for mean differences from the ANOV A was not signifIcant, (F[ 4, 132] = 0.91, P > 0.38). Although Spearman correlations would be more appropriate to describe this set of data, the Pear son correlations shown in Table 3 are relevant to the assumptions of the ANOV A. These correlations show The Friedman statistic may be a more appropriate ana lytic method for this data since no normality assump tion is necessary and our data are distinctively nonnor mal. The Friedman approach makes inferences about the relative intraindividual ranks of the time-period rat ings rather than about their absolute magnitude. In traindividual change is accounted for by ranking each subject's scores from the lowest to the highest severity period, yielding T ranks ranging from 1 to T. The null hypothesis is that there is no consistent buildup of higher or lower ranks at any measurement period. A tendency for the highest ranks (e.g. , subjects' worst symptom severity) to appear in the 1st week would lead to a rejection of the null hypothesis. Formulas for com puting the Friedman analysis and exact probabilities for small samples are given by Siegel (1956) and Siegel and Castellan (1988) . Computationally, a standard repeated measures ANOV A calculated on the within-subject ranks will also produce F statistics and excellent small sample p-value approximations (Conover and Iman 1976) . Using this technique is preferable to the standard 'X.2 when the number of times is larger than the num ber of subjects (Iman and Davenport 1980) . The average ranks for each of the £lve weekly rat ings appear in Table 4 as do the frequencies of each rank. This table and the signifIcance tests use the 34 subjects with complete data. The Friedman analysis produces an F(4, 132) = 2.61, P < 0.038. Using the X2(4) approxi mation we fmd a value of 9.96, P < 0. 041. Thus, we can conclude that there is a pattern to the relative rankings during the antipsychotic medication washout period. Judging from Table 4 , the worst week (ranks 4. 5 to 5) tended to occur at the beginning of the washout period and tapered off. Many subjects (38%) were experienc ing their worst week at Week 1 and only 6% experienced Week 5 as their worst.
Nonparametric Method 2: Cochran-Mantel-Haenszel
Statistics
Although Friedman's test does not require that the re sponse variable is continuous or normally distributed, it only uses complete cases. We now describe a method based on the use of CMH statistics (Agresti 1990; Landis et al. 1988; Mantel and Haenszel 1963; Mantel 1963) for analyzing one-sample repeated measures. Unlike other techniques, the CMH method can readily include sub jects with incomplete data. Of course, the reasons that data are missing need to be irrelevant to the study (e. g. , random or happenstance). To be more precise, any missing data must be missing completely at random (Rubin 1976) . Individual subjects are strata for this use of the CMH analysis. The use of CMH statistics is quite common in epidemiology; however, the application to repeated-measures data is less well known.
The general framework is as follows. Let N, T, and L denote the number of subjects, the number of time periods, and the number of possible levels of the re sponse variable, respectively. The resulting data are summarized in N T x L contingency tables, one table for each of the N subjects. For instance, one subject in our sample received the SA ratings of 5, 2, 1, 3, and 2 for the five time periods, respectively. The contin gency table for this individual depicts "l's" for row (week) 1 and column (score) 5, row (week) 2 and column (score) 2, and so on. Zeros fill the remainder of the ta ble (Table 5) . In this example, L, the number of possi ble outcomes on the rating scale, is relatively small; however, there is no restriction on the number of pos- sible outcomes in the variable. Thus, the CMH meth odology described in this paper is equally applicable to continuous outcome variables. The CMH statistics are summary test statistics for the independence of the ranked ratings (rows) from time (columns). Statistical inference is based on the mul tiple hypergeometric distribution; the row and column margin totals in each table are fixed. The only assump tions are independence between subjects and an order to the ratings (e. g. , worst to least severe). Rejection of the null hypothesis indicates that the ranks tend to change as a function of the time period. Two versions of the test are commonly available: 1) a test sensitive to a monotonic correlation between the scores and time periods analogous to a Spearman correlation, and 2) a test for the time period differences in mean ranks anal ogous to a Friedman Analysis of Ranks. Both test statis tics are easily obtained using the FREQ procedure of SAS (1990) .
For comparison with the previous analyses we first used the sample of subjects with complete data (n = 34). The CMH test for differences in mean ranks yields a value of 9. 955 (df = 4, P < 0.041). This is numerically equivalent to the X2 approximation found with the Friedman analysis. There is also a substantial mono tonic relation (CMH statistic = 7. 726, df = 1, P < 0. 005) between the SA ratings and time. This supports our interpretation of Tables 2 and 4 that generally subjects' worst symptoms occur early in the period and then de cline in severity. The fact that the CMH approach can accommodate subjects for whom we do not have complete data is a major advantage. The CMH statistics do not require that all weeks (columns) be complete in the T x L contin gency tables. In all of the previous analyses, only 34 cases with data present on all five occasions could be used. This gives 170 (i. e. , 34 x 5) datapoints. If we in clude our nine subjects with missing data, the yield to tals 201 valid observations, an 18% increase in the num ber of subjects. Based on all 43 subjects, the CM H statistic for differences increased to 12.153 (df = 4, P < 0. 016) and for the monotonic correlation to 8. 831 (df = 1, P < 0. 003). in order to locate a signifIcant result, rather we wished to demonstrate that the various methods each test sub tl y diff erent hypotheses and each has its own benefIts and de ftcits. It is oversimplifying to suggest that any one te chnique should be the standard method; how ever, the CMH or Friedman approach may often be more appropriate for analyzing repeated measures in psychiatric research. This is particularly true when the data do not meet the basic assumptions required of parametric analyses.
We found that 43% of the patients receiving a vari ety of antipsychotic medications had clinically signi bcant DIP. Eighty-eight percent of our patients were receiving high-potency antipsychotics alone, which makes this rate consistent with previous reports (Ayd 1%1; Korczyn and Goldberg 1976; Sheppard and Merlis 1%7; Tarsy 1983) . Although these symptoms tend to wax and wane over time, they generally resolve with dis continuation of antipsychotic medications. We assumed that since there was a substantial number of patients with DIP at baseline, the mean severity ratings would change signifIcantly during a 4-week washout period.
We were surprised that there was no mean change in weekly SA ratings over the 4-week washout period when analyzed by ANOVA and MANOVA. However, the repeated-measure ANOV A and MANOV A had gross violations of their assumptions occurring in the present dataset. Despite the restrictive assumptions, we included them for two reasons: 1) due to their popularity and recent suggestions to use MANOV A made by Ekstrom, et al. (1990) and others (Poor 1973; McCall and Appelbaum 1973; Keselman and Rogan 1980) ; and 2) to demonstrate that they can often be an inappropriate choice for psychiatric data. Paired t-tests are a special case for both of these methods so that some of the issues raised in this discussion apply to this sim ple test statistic as well. On the other hand, the CMH method's ability to accept cases with incomplete data is a powerful advan tage. Losing an entire subject because of a missing datapoint is a high price to pay and may be unaccept able for any number of reasons. For instance, if costly or invasive procedures are involved, it is vital to main tain the data already obtained. A subgroup that con sists of only "perfect completers" may be very atypical of the group as a whole, substantially reducing the generalizability of the results. Statistical power is also severely compromised. Providing that the data is not missing due to any factor related to the study, the CMH approach effectively minimizes the information loss and maintains generalizability by retaining as many subjects A simple but widely-used alternative that was not considered in this paper is response-feature analysis (Crowder and Hand 1990) . The basic idea is to replace the repeated measures for each individual subject by a single-summary statistic indicating their trajectory or changes. Thus, a multivariate analysis is reduced to a univariate analysis. Response-feature analysis is use ful not only in one-sample situations, but extends eas ily to between-subject factors. For these data, the within-person association of score with time could be summarized by a single measure of association such as a regression slope or the Spearman rank correlation coefficient. The resulting measures could then be ana lyzed for a nonzero mean or differences between groups. Although this principle is very similar to the use of the CMH correlation statistic, the CMH mean score statistic offers the advantage of being able to de tect nonmonotonic relationships.
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